BioLASCO Taiwan , Ltd. Total Liabilities

BioLASCO Taiwan , Ltd. (6662.TWO) currently reports a total liabilities of $170M as of June 2026. That compares with $180M in the prior-year period — down 7.6% year over year. Use the charts on this page to explore BioLASCO Taiwan , Ltd.'s total liabilities history and peer comparisons.

BioLASCO Taiwan , Ltd.'s total liabilities decreased from $180M to $170M — a 7.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioLASCO Taiwan , Ltd. reported $170M in total liabilities as of June 2026. That compares with $180M in the prior-year period — down 7.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioLASCO Taiwan , Ltd., and consider following 6662.TWO for alerts when major investors trade the stock.

BioLASCO Taiwan , Ltd. is classified in the Healthcare sector. On total liabilities, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6662.TWO with unrelated industries.